A phase III clinical trial of intranasal Naloxone (NS-001) in opioid overdose
Latest Information Update: 21 Oct 2020
At a glance
- Drugs Naloxone (Primary)
- Indications Opioid-related disorders
- Focus Therapeutic Use
- 21 Oct 2020 New trial record
Latest Information Update: 21 Oct 2020